Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCD-054 PK/PD Study in Healthy Volunteers
NCT02359877Phase 1Completed
- Sponsor
- BIOCAD
- Start
- Jul 2014
- Primary completion
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sampeginterferon beta-1a in multiple sclerosis (MS) (3 arms), sponsored by BIOCAD. Primary endpoints: Area Under the Curve, Area Under the Curve of Neopterin and 1 more. Started Jul 2014; status: completed.
02
Drugs
sampeginterferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02359877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359877.